FAOIX
Price
$38.75
Change
-$0.07 (-0.18%)
Updated
Sep 12 closing price
Net Assets
458.96M
RERAX
Price
$59.28
Change
-$0.03 (-0.05%)
Updated
Sep 12 closing price
Net Assets
134.85B
Interact to see
Advertisement

FAOIX vs RERAX

Header iconFAOIX vs RERAX Comparison
Open Charts FAOIX vs RERAXBanner chart's image
Fidelity Advisor Overseas I
Price$38.75
Change-$0.07 (-0.18%)
VolumeN/A
Net Assets458.96M
American Funds EUPAC R1
Price$59.28
Change-$0.03 (-0.05%)
VolumeN/A
Net Assets134.85B
FAOIX vs RERAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FAOIX vs. RERAX commentary
Sep 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FAOIX is a Buy and RERAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RERAX has more cash in the bank: 135B vs. FAOIX (459M). FAOIX pays higher dividends than RERAX: FAOIX (1.40) vs RERAX (0.23). FAOIX was incepted earlier than RERAX: FAOIX (30 years) vs RERAX (23 years). RERAX (1.57) is less costly to investors than FAOIX (0.77). RERAX (35.00) and FAOIX (34.00) have comparable annual turnover. FAOIX has a lower initial minimum investment than RERAX: FAOIX (0) vs RERAX (250). FAOIX annual gain was more profitable for investors over the last year : 12.58 vs. RERAX (8.92). FAOIX return over 5 years is better than : 49.51 vs. RERAX (9.89).
FAOIXRERAXFAOIX / RERAX
Total Expense Ratio0.771.5749%
Annual Report Gross Expense Ratio0.771.5749%
Fund Existence30 years23 years-
Gain YTD20.30417.549116%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets459M135B0%
Annual Yield % from dividends1.400.23613%
Returns for 1 year12.588.92141%
Returns for 3 years60.1033.97177%
Returns for 5 years49.519.89501%
Returns for 10 years86.7835.58244%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OCCIO24.97N/A
N/A
OFS Credit Company
GROV1.54N/A
N/A
Grove Collaborative Holdings
COGT12.66-0.15
-1.17%
Cogent Biosciences
SPXC186.32-3.93
-2.07%
SPX Technologies
CLSD0.32-0.03
-8.61%
Clearside Biomedical